Russia and China are racing to plug the COVID-19 vaccine gap in Africa, hoping to cement their influence on a continent where many countries have yet to administer a single shot.
However, so far, vaccine donations from Beijing and Moscow have been small, the commercial deals they offer are costly, and some African governments are wary about a lack of data.
As rich countries ramp up their inoculation drives, Africa, without the resources to pre-order Pfizer, AstraZeneca, Moderna and Johnson & Johnson vaccines, is being left behind.
Illustration: Yusha
With Western nations facing criticism for hoarding supplies, flooding Africa with life-saving shots would be a soft-power coup for Russia and China.
Moscow has offered 300 million doses with financing to an African Union (AU) purchasing scheme.
Beijing has pledged nearly one-quarter of all its vaccine donations to Africa, according to data compiled by Bridge Consulting, a Beijing-based health sector advisory.
“This is a vivid manifestation of China-Africa friendship,” the Chinese Ministry of Foreign Affairs told reporters.
“Africa is one of the key markets for Sputnik V,” said the Russian Direct Investment Fund (RDIF), the sovereign wealth fund marketing its Sputnik V vaccine abroad.
French President Emmanuel Macron has said Europe and the US risk losing influence in Africa over the issue.
However, Africa Centres for Disease Control and Prevention Director John Nkengasong cautioned against “vaccine diplomacy,” saying powers must not use token allocations to curry political influence.
“Africa will refuse to be that playing ground where we use COVID as a tool to manage relationships,” he said on a Webinar hosted by the Atlantic Council think tank late last month.
“It becomes like you’re trying to sprinkle water on a very hot day on children... Then you can tick the box that you did that,” he said. “That’s not what we are after as a continent.”
While other developing regions have turned to Russia or China, in Africa their engagement has translated into few shots in arms.
Africa has received about 3.15 million shots from China — or less than 4 percent of its vaccine exports — Bridge Consulting data showed.
“The numbers of vaccines China is donating are not going to move the needle in any of these countries. But it’s as much about the optics,” China-Africa Project cofounder Eric Olander said.
Russia has shipped a total of about 100,000 vaccine doses to Algeria, Tunisia and Guinea.
Meanwhile, the global vaccine sharing scheme COVAX delivered nearly 15 million shots to 22 African countries in its first 10 days.
The facility co-led by the WHO, GAVI and others aims to ship 35 million doses to Africa by the end of this month and 720 million by the end of this year.
That would still only be enough to inoculate those at greatest risk.
DATA DEFICIT
China’s leading vaccines — from the China National Pharmaceutical Group (Sinopharm) and Sinovac — are not yet approved for emergency use by the WHO. Neither is Russia’s Sputnik V vaccine.
China offered South Africa — the African nation hardest hit by the pandemic — 2 million shots, the South African minister of health said.
However, a government official involved in procurement told reporters that the lack of trial data meant Chinese vaccines were not being seriously considered for now.
Sputnik V was also relegated to a second tier of vaccines that South Africa says need more study, the South African Ministry of Health said.
Even some countries that accepted donations have shied away from purchases.
Uganda considered buying Chinese vaccines, but is focused on COVAX due to their cost and the availability of data, said Ombeva Malande, director of the East Africa Center for Vaccines and Immunization, which advised the government.
Kenya is taking a similar line, he said.
Diana Atwine, permanent secretary in the Ugandan Ministry of Health, said authorities would consider affordable vaccines approved by the WHO.
The head of Kenya’s vaccine task force confirmed that it was not in talks to procure Chinese vaccines, and health ministry plans do not include Russian vaccines.
DOLLARS AND DOSES
While COVAX shots are free for most African nations, countries doing commercial deals are paying a premium.
Senegal paid US$20 a shot for 200,000 doses of Sinopharm, a two-shot vaccine.
“The worst thing that could happen now is for countries to not start vaccinating,” said Tandakha Ndiaye Dieye, a member of Senegal’s vaccine advisory group, explaining the decision.
By comparison, India’s Serum Institute is selling AstraZeneca shots it manufactures for US$3. The Indian government has also donated more than 500,000 of those shots to eight African countries, according to a Reuters tally.
Beijing has so far not announced financing packages that would make vaccine deals more affordable in Africa.
At about US$10 per dose, Sputnik V is cheaper, and the RDIF told reporters that it would be even more competitive if subsidized via COVAX.
The RDIF said it was in “advanced negotiations” with the WHO to be included in COVAX and could offer a one-shot version to reduce the cost.
A spokesperson for GAVI, the global vaccine alliance helping lead COVAX, said all vaccines would be considered, but they first needed approval from the WHO or another stringent regulatory authority.
The RDIF said some deliveries of the Sputnik V doses offered via the AU plan could start in May.
A senior AU diplomat told reporters that talks were taking place, but no agreement had been reached. No details have been announced about the finance package. The RDIF did not respond to questions about the potential deal.
Both China and Russia must increase production if they hope to become major global vaccine suppliers. For Moscow, exporting shots is politically sensitive when its own population still needs vaccinating.
“I’m not worried about whether Russia’s going to be able to deliver the doses,” said Gyude Moore of the Center for Global Development, a Washington think tank. “I’m worried about how African countries are going to pay for them ... COVAX is just not going to be enough.”
The first Donald Trump term was a boon for Taiwan. The administration regularized the arms sales process and enhanced bilateral ties. Taipei will not be so fortunate the second time around. Given recent events, Taiwan must proceed with the assumption that it cannot count on the United States to defend it — diplomatically or militarily — during the next four years. Early indications suggested otherwise. The nomination of Marco Rubio as US Secretary of State and the appointment of Mike Waltz as the national security advisor, both of whom have expressed full-throated support for Taiwan in the past, raised hopes that
There is nothing the Chinese Nationalist Party (KMT) could do to stop the tsunami-like mass recall campaign. KMT Chairman Eric Chu (朱立倫) reportedly said the party does not exclude the option of conditionally proposing a no-confidence vote against the premier, which the party later denied. Did an “actuary” like Chu finally come around to thinking it should get tough with the ruling party? The KMT says the Democratic Progressive Party (DPP) is leading a minority government with only a 40 percent share of the vote. It has said that the DPP is out of touch with the electorate, has proposed a bloated
In an eloquently written piece published on Sunday, French-Taiwanese education and policy consultant Ninon Godefroy presents an interesting take on the Taiwanese character, as viewed from the eyes of an — at least partial — outsider. She muses that the non-assuming and quiet efficiency of a particularly Taiwanese approach to life and work is behind the global success stories of two very different Taiwanese institutions: Din Tai Fung and Taiwan Semiconductor Manufacturing Co (TSMC). Godefroy said that it is this “humble” approach that endears the nation to visitors, over and above any big ticket attractions that other countries may have
A media report has suggested that Chinese Nationalist Party (KMT) Chairman Eric Chu (朱立倫) was considering initiating a vote of no confidence in Premier Cho Jung-tai (卓榮泰) in a bid to “bring down the Cabinet.” The KMT has denied that this topic was ever discussed. Why might such a move have even be considered? It would have been absurd if it had seen the light of day — potentially leading to a mass loss of legislative seats for the KMT even without the recall petitions already under way. Today the second phase of the recall movement is to begin — which has
RSS